Clinical trial
The Anti-Diabetic and Cholesterol-Lowering Effects of Cinnamon and Cassia Bark
NCT00479973 · University Health Network, Toronto, Other · Unknown status
Key facts
| NCT number | NCT00479973 |
|---|---|
| Title | The Anti-Diabetic and Cholesterol-Lowering Effects of Cinnamon and Cassia Bark |
| Official title | The Anti-Diabetic and Cholesterol-Lowering Effects of Cinnamon and Cassia Bark (Cinnamomum Verum and C. Aromaticum) (Cinnamonforce™) - Randomized Placebo-Controlled Clinical Trial |
| Lead sponsor | University Health Network, Toronto, Other |
| Collaborators | The Canadian College of Naturopathic Medicine |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Type 2 Diabetes, Hypercholesterolemia |
| Intervention type | Dietary Supplement |
| Interventions | Cinnamonforce, Placebo |
| Enrollment | 70 |
| Start date | Sep 1, 2007 |
| Completion | May 1, 2008 |
| First posted | May 30, 2007 |
| Last update posted | Nov 20, 2007 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: